INHIBITION OF CIMETIDINE-INDUCED HYPERPROLACTINAEMIA BY PRETREATMENT WITH LEVODOPA OR BROMOCRIPTINE
- 1 January 1979
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 10 (1) , 93-95
- https://doi.org/10.1111/j.1365-2265.1979.tb03037.x
Abstract
Cimetidine, an histamine H2-receptor antagonist, employed in the treatment of peptic ulcers, sometimes causes gynecomastia and galactorrhoea. A single i.v. administration of cimetidine produced a significant increase in serum prolactin (PRL) levels in 15 normal men. This effect was suppressed by pretreatment with L-dopa or bromocriptine.This publication has 4 references indexed in Scilit:
- PLASMA-PROLACTIN AND CIMETIDINEThe Lancet, 1978
- CIMETIDINE, AN H2-ANTIHISTAMINE, STIMULATES PROLACTIN SECRETION IN MANJournal of Clinical Endocrinology & Metabolism, 1977
- GALACTORRH$OElig;A WITH CIMETIDINEThe Lancet, 1977
- GYNÆCOMASTIA WITH CIMETIDINEThe Lancet, 1977